Cargando…

Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson’s Disease

Parkinson’s disease (PD) is a chronic and progressive disorder characterized neuropathologically by loss of dopamine neurons in the substantia nigra, intracellular proteinaceous inclusions, reduction of dopaminergic terminals in the striatum, and increased neuroinflammatory cells. The consequent red...

Descripción completa

Detalles Bibliográficos
Autores principales:	Subramaniam, Sudhakar R., Federoff, Howard J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463358/ https://www.ncbi.nlm.nih.gov/pubmed/28642697 http://dx.doi.org/10.3389/fnagi.2017.00176

Ejemplares similares

Microglial Phagocytosis and Its Regulation: A Therapeutic Target in Parkinson’s Disease?
por: Janda, Elzbieta, et al.
Publicado: (2018)

Microglial Activation and Antioxidant Responses Induced by the Parkinson’s Disease Protein α-Synuclein
por: Béraud, Dawn, et al.
Publicado: (2012)

Pharmacological Targeting of Microglial Activation: New Therapeutic Approach
por: Liu, Cai-Yun, et al.
Publicado: (2019)

Microglial Turnover in Ageing-Related Neurodegeneration: Therapeutic Avenue to Intervene in Disease Progression
por: Azam, Shofiul, et al.
Publicado: (2021)

New Therapeutic Avenues of mCSF for Brain Diseases and Injuries
por: Pons, Vincent, et al.
Publicado: (2018)

Pathogenic Aspects and Therapeutic Avenues of Autophagy in Parkinson’s Disease
por: Kinet, Rémi, et al.
Publicado: (2023)

Modulation of Microglial Activity by Rho-Kinase (ROCK) Inhibition as Therapeutic Strategy in Parkinson’s Disease and Amyotrophic Lateral Sclerosis
por: Roser, Anna-Elisa, et al.
Publicado: (2017)

The role of microglial autophagy in Parkinson’s disease
por: Zhu, Rui, et al.
Publicado: (2022)

Clinical PET Imaging of Microglial Activation: Implications for Microglial Therapeutics in Alzheimer’s Disease
por: Shen, Zhiwei, et al.
Publicado: (2018)

Microglial autophagy in Alzheimer’s disease and Parkinson’s disease
por: Wang, Zhifu, et al.
Publicado: (2023)

Role of G Protein-Coupled Receptors in Microglial Activation: Implication in Parkinson’s Disease
por: Gu, Chao, et al.
Publicado: (2021)

Tweaking Progranulin Expression: Therapeutic Avenues and Opportunities
por: Terryn, Joke, et al.
Publicado: (2021)

Mechanotransduction: Exploring New Therapeutic Avenues in Central Nervous System Pathology
por: Rocha, Daniela Nogueira, et al.
Publicado: (2022)

Editorial: Microglial Polarization in the Pathogenesis and Therapeutics of Neurodegenerative Diseases
por: Tang, Yu
Publicado: (2018)

GW5074 Increases Microglial Phagocytic Activities: Potential Therapeutic Direction for Alzheimer’s Disease
por: Connor, Sarah M., et al.
Publicado: (2022)

Decoding the role of gut microbiota in Alzheimer’s pathogenesis and envisioning future therapeutic avenues
por: Liang, Junyi, et al.
Publicado: (2023)

Metabolic Mechanisms Connecting Alzheimer’s and Parkinson’s Diseases: Potential Avenues for Novel Therapeutic Approaches
por: Colca, Jerry R., et al.
Publicado: (2022)

New Avenues for Parkinson’s Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota
por: Lorente-Picón, Marina, et al.
Publicado: (2021)

Microglial Activation in the Pathogenesis of Huntington’s Disease
por: Yang, Hui-Ming, et al.
Publicado: (2017)

Microglial pyroptosis: Therapeutic target in secondary brain injury following intracerebral hemorrhage
por: Gu, Lingui, et al.
Publicado: (2022)

Immune Responses in Parkinson's Disease: Interplay between Central and Peripheral Immune Systems
por: Su, Xiaomin, et al.
Publicado: (2014)

Microglial Implication in Parkinson’s Disease: Loss of Beneficial Physiological Roles or Gain of Inflammatory Functions?
por: Lecours, Cynthia, et al.
Publicado: (2018)

From Cannabinoids and Neurosteroids to Statins and the Ketogenic Diet: New Therapeutic Avenues in Rett Syndrome?
por: Mouro, Francisco Melo, et al.
Publicado: (2019)

Targeting IgG in Arthritis: Disease Pathways and Therapeutic Avenues
por: Nandakumar, Kutty Selva
Publicado: (2018)

PU-91 drug rescues human age-related macular degeneration RPE cells; implications for AMD therapeutics
por: Nashine, Sonali, et al.
Publicado: (2019)

Gut and Brain: Investigating Physiological and Pathological Interactions Between Microbiota and Brain to Gain New Therapeutic Avenues for Brain Diseases
por: Deidda, Gabriele, et al.
Publicado: (2021)

The class II histone deacetylases as therapeutic targets for Parkinson’s disease
por: Mazzocchi, Martina, et al.
Publicado: (2020)

Gene Therapy for the Treatment of Parkinson’s Disease: The Nature of the Biologics Expands the Future Indications
por: Fiandaca, Massimo S., et al.
Publicado: (2012)

Targeting calcium signaling in Alzheimer’s disease: challenges and promising therapeutic avenues
por: Song, LinLin, et al.
Publicado: (2023)

Importance of GPCR-Mediated Microglial Activation in Alzheimer’s Disease
por: Haque, Md. Ezazul, et al.
Publicado: (2018)

Microglial Ion Channels as Potential Targets for Neuroprotection in Parkinson's Disease
por: Richardson, Jason R., et al.
Publicado: (2013)

Microglial control of neuronal activity
por: Béchade, Catherine, et al.
Publicado: (2013)

Microglial Exosomes in Neurodegenerative Disease
por: Guo, Min, et al.
Publicado: (2021)

Microglial autophagy in cerebrovascular diseases
por: Chen, Man, et al.
Publicado: (2022)

Targeting trafficking as a therapeutic avenue for misfolded GPCRs leading to endocrine diseases
por: Ulloa-Aguirre, Alfredo, et al.
Publicado: (2022)

Gene targeting as a therapeutic avenue in diseases mediated by the complement alternative pathway
por: Dreismann, Anna K, et al.
Publicado: (2022)

The impact of microglial activation on blood-brain barrier in brain diseases
por: da Fonseca, Anna Carolina Carvalho, et al.
Publicado: (2014)

Microglial Phenotypes and Their Relationship to the Cannabinoid System: Therapeutic Implications for Parkinson’s Disease
por: Kelly, Rachel, et al.
Publicado: (2020)

Microglial Activation in Traumatic Brain Injury
por: Donat, Cornelius K., et al.
Publicado: (2017)

Novel astrocyte targets: New Avenues for the Therapeutic Treatment of Epilepsy
por: Crunelli, Vincenzo, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_o0jjshui527n8ctqhj909a2cf6